Rubius Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2019 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Rubius Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2019 to Q4 2022.
  • Rubius Therapeutics, Inc. Return On Assets for the quarter ending December 31, 2022 was -104 %, a 99.4% decline year-over-year.
  • Rubius Therapeutics, Inc. annual Return On Assets for 2022 was -104 %, a 99.4% decline from 2021.
  • Rubius Therapeutics, Inc. annual Return On Assets for 2021 was -52.2 %, a 0.13% increase from 2020.
  • Rubius Therapeutics, Inc. annual Return On Assets for 2020 was -52.3 %, a 36.5% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -104 -51.9 -99.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -87.1 -37.4 -75.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -68.3 -19.2 -39.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -61.6 -14.2 -30% Jan 1, 2022 Mar 31, 2022
Q4 2021 -52.2 +0.07 +0.13% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.7 -0.66 -1.35% Jul 1, 2021 Sep 30, 2021
Q2 2021 -49.1 -2.31 -4.94% Apr 1, 2021 Jun 30, 2021
Q1 2021 -47.4 -2.89 -6.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -52.3 -14 -36.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -49.1 -16.4 -50.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -46.8 -19.1 -68.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -44.5 -17.3 -63.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -38.3 Oct 1, 2019 Dec 31, 2019
Q3 2019 -32.7 Jul 1, 2019 Sep 30, 2019
Q2 2019 -27.7 Apr 1, 2019 Jun 30, 2019
Q1 2019 -27.2 Jan 1, 2019 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.